|
Status |
Public on Dec 08, 2011 |
Title |
Homo_sapiens_genome_rep2_C |
Sample type |
genomic |
|
|
Channel 1 |
Source name |
FoxA1 ChIP DNA (abl)
|
Organism |
Homo sapiens |
Characteristics |
cell line: abl antibody: FoxA1 phenotype: androgen-independent antibody manufacturer: Abcam antibody catalog #: ab23738
|
Growth protocol |
LNCaP and abl were cultured in RPMI 1640/10% FBS and RPMI 1640/10% charcoal-stripped FBS, respectively.
|
Extracted molecule |
genomic DNA |
Extraction protocol |
FoxA1 ChIP was performed followed by amplification using ligation-mediated PCR.
|
Label |
biotin
|
Label protocol |
The amplified ChIP'ed DNA was labelled with biotin.
|
|
|
Channel 2 |
Source name |
FoxA1 ChIP DNA (LNCaP)
|
Organism |
Homo sapiens |
Characteristics |
phenotype: androgen-dependent cell line: LNCaP antibody: FoxA1 antibody manufacturer: Abcam antibody catalog #: ab23738
|
Growth protocol |
LNCaP and abl were cultured in RPMI 1640/10% FBS and RPMI 1640/10% charcoal-stripped FBS, respectively.
|
Extracted molecule |
genomic DNA |
Extraction protocol |
FoxA1 ChIP was performed followed by amplification using ligation-mediated PCR.
|
Label |
biotin
|
Label protocol |
The amplified ChIP'ed DNA was labelled with biotin.
|
|
|
|
Hybridization protocol |
standard Affymetrix protocol
|
Scan protocol |
standard Affymetrix protocol
|
Description |
replicate-2 chip-C
|
Data processing |
Supplementary files contain results from Model Based analysis of tiling arrays (MAT) was used to process the data as described previously: Johnson, et al, 2006, PMID: 16895995
|
|
|
Submission date |
Dec 28, 2010 |
Last update date |
Jun 25, 2013 |
Contact name |
LIGUO WANG |
E-mail(s) |
wang.liguo@mayo.edu
|
Organization name |
Mayo Clinic
|
Department |
Division of Computational Biology
|
Street address |
200 1st St SW
|
City |
Rochester |
State/province |
MN |
ZIP/Postal code |
55905 |
Country |
USA |
|
|
Platform ID |
GPL4912 |
Series (1) |
GSE26329 |
MYBL2/CREB1-Dependent Distinct FoxA1 Cistrome Directs G1/S Cell Cycle Progression in Androgen-Independent Prostate Cancer |
|